GLP-3 (RT) 20mg

Introduction

Retatrutide 20mg is a high-purity research peptide supplied as a white lyophilized powder in a 3mL vial. Researchers study this peptide in laboratory environments to explore metabolism, energy balance, and obesity-related pathways.

This compound is commonly known in research as Retatrutide, a triple-agonist peptide designed to interact with multiple metabolic hormone receptors. Because of this multi-pathway activity, it has become an important compound for scientists investigating appetite regulation, glucose metabolism, and body weight control.

The peptide is widely used in experimental metabolic studies where researchers aim to understand how hormonal signals influence fat storage and energy use. Retatrutide’s unique mechanism makes it a valuable tool for modern obesity and metabolic research.

How GLP-3 (RT) Works in Research

Retatrutide 20mg functions as a triple receptor agonist in laboratory studies. Researchers examine how this peptide influences metabolic signaling pathways that regulate appetite, glucose levels, and energy expenditure.

The compound interacts with three important receptors involved in metabolic regulation, allowing scientists to study several physiological processes at the same time.

GLP-1, GIP, and Glucagon Receptor Activation

Retatrutide activates GLP-1, GIP, and glucagon receptors, three hormone pathways involved in metabolic control. These receptors play a central role in regulating insulin response, appetite signals, and energy expenditure.

Scientists analyze how this combined receptor activity may influence glucose metabolism, caloric intake, and fat processing in experimental models.

Effects on Fat Metabolism

In research settings, Retatrutide 20mg peptides are studied for their potential influence on lipid metabolism and energy utilisation. The peptide may help researchers examine how fat is broken down and how metabolic pathways adjust during changes in calorie balance.

Understanding these mechanisms helps scientists explore biological processes associated with obesity and metabolic disorders.

Appetite and Energy Balance

Another important focus of Retatrutide research is appetite signalling. In laboratory studies, the peptide may influence hunger-related pathways that regulate food intake and satiety.

By observing these effects, researchers can investigate how hormones interact to maintain long-term energy balance and body weight regulation.

Research Insights

Retatrutide (GLP-3 RT) has gained attention in metabolic science because it acts on multiple hormone receptors simultaneously. Early studies show that this triple-agonist activity can influence body weight regulation, glucose control, and energy expenditure in experimental models.

Research continues to explore how these combined pathways contribute to metabolic balance and appetite control. Because of its broad metabolic activity, GLP-3 (RT) is increasingly used in laboratory investigations focused on obesity and energy metabolism.

Product Specifications

1. Form: Lyophilized white powder, 20mg per 3mL vial
2. Purity: ≥99% research-grade peptide
3. Chemical Formula: C₂₂₃H₃₄₃F₃N₄₆O₇₀
4. Molecular Weight: ~4845.44 g/mol
5. CAS Number: 2381089-83-2
6. PubChem CID: 474492235
7. Appearance: Sterile white powder in a glass vial
8. Storage: Store sealed at ≤25°C away from heat, light, and moisture
9. Reconstitution: Use sterile solvent such as bacteriostatic water (BAC water)
10. Lab Use: Intended for metabolic and obesity research applications

Usage Guidelines for Research

GLP-3 (RT) 20mg is supplied for laboratory research use only and is not intended for human consumption.

Recommended laboratory handling practices include:

1. Reconstitute using sterile bacteriostatic water or suitable solvent
2. Use sterile lab tools and containers to prevent contamination
3. Start with small research concentrations when conducting experiments
4. Follow laboratory safety procedures and wear protective equipment
5. Store prepared solutions properly and dispose of materials according to lab protocols

Retatrutide Dosage Calculator

Researchers often use a Retatrutide dosage calculator to determine the correct peptide concentration after reconstitution. By adding a sterile solvent such as bacteriostatic water (BAC water) to the 20mg vial, scientists can calculate the desired concentration for laboratory experiments.

For example, adding 2 mL of BAC water to a 20mg vial results in a concentration of 10 mg per mL. A Retatrutide dosage calculator helps simplify these calculations and ensures accurate preparation for research protocols.

Advantages of GLP-3 (RT) 20mg

GLP-3 (RT) 20mg provides reliable performance for laboratory research due to its purity and stability. Its multi-receptor activity allows researchers to examine several metabolic pathways simultaneously.

Key advantages include:

1. ≥99% high-purity research peptide
2. Stable lyophilized powder format
3. Easy reconstitution with sterile solvent
4. Reliable research consistency
5. Useful for metabolic and obesity studies

These properties make the peptide suitable for laboratories studying metabolism, appetite signalling, and energy balance.

Comparisons

Application and Availability

GLP-3 (RT) 20mg is commonly used in research focused on metabolic function, obesity mechanisms, and appetite regulation. Scientists study this peptide to better understand how hormonal pathways influence body weight, glucose balance, and fat metabolism.

The peptide is available to qualified laboratories and scientific institutions conducting peptide-based metabolic research. Due to growing interest in multi-receptor peptides, availability may sometimes be limited.

Researchers can obtain GLP-3 (RT) peptides from trusted suppliers that provide laboratory-grade materials for scientific study.

Conclusion

GLP-3 (RT) 20mg is a high-purity research peptide widely studied for its role in metabolism and energy regulation. Its triple-receptor activity involving GLP-1, GIP, and glucagon pathways makes it a valuable compound for metabolic and obesity research.

With reliable purity and stable laboratory performance, GLP-3 (RT) continues to be an important peptide for scientists investigating appetite control, fat metabolism, and metabolic signalling.

References

1. Frias, J. P., Bastyr, E. J., Vignati, L., et al. (2018). Efficacy and safety of LY3298176, a dual GIP and GLP-1 receptor agonist in type 2 diabetes. The Lancet, 392(10160), 2180–2193.
2. Coskun, T., Sloop, K. W., Loghin, C., et al. (2022). LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist, improves body weight and glucose control in patients with type 2 diabetes. Cell Metabolism, 35(6), 1078–1091.e6.
3. Nauck, M. A., Quast, D. R., Wefers, J., & Meier, J. J. (2021). GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art. Molecular Metabolism, 46, 101102.